KDR and nonpapillary renal cell carcinoma: HLA‐I expression levels have been linked to overall prognosis in ccRCC, as well as specific response rates to TKIs, providing a rationale for evaluating both PD‐L1 and HLA‐I in correlation with response to VEGF‐R TKIs and ICIs [8, 12].